Drugs / BoostrixTM Polio
BoostrixTM Polio
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01323959 | Apr 2011 → Mar 2012 | diphtheria, poliomyelitis, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BoostrixTM Polio | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01323959 ↗ |
| Known as | Boostrix-polio | “received a single decennial booster dose of dTpa-IPV (Boostrix-polio, GlaxoSmithKline Vaccines).” PMID 25882172 ↗ Apr 2015 |
| Known as | dTpa-IPV | “received a single decennial booster dose of dTpa-IPV (Boostrix-polio, GlaxoSmithKline Vaccines).” PMID 25882172 ↗ Apr 2015 |
| Modality | Vaccine | “poliovirus booster vaccine (dTpa-IPV)” PMID 25882172 ↗ Apr 2015 |
| Route | Intramuscular | “Single dose, intramuscular administration.” NCT01323959 ↗ |